A Double-Blind Placebo-Controlled Pilot Study of Safety and Tolerability of AIMSPRO in Established Diffuse Cutaneous Systemic Sclerosis
Latest Information Update: 25 Jul 2019
At a glance
- Drugs Caprine serum (Primary)
- Indications Systemic scleroderma
- Focus Therapeutic Use
- Sponsors Daval International
- 25 Feb 2014 Status changed from active, no longer recruiting to completed based on information reported in a Daval International media release.
- 25 Feb 2014 This trial has been completed recently according to a Daval International media release.
- 03 Dec 2013 New trial record